Update on the epidemiology of carbapenemases in Latin America and the Caribbean

Vista sencilla de ítem
dc.contributor.authorGarcia Betancur, Juan Carlos
dc.contributor.authorAppel, Tobias Manuel
dc.contributor.authorEsparza, Germán Francisco
dc.contributor.authorGales, Ana
dc.contributor.authorLevy-Hara, Gabriel
dc.contributor.authorCornistein, Wanda
dc.contributor.authorVega, Silvio
dc.contributor.authorNuñez, Duilio
dc.contributor.authorCuellar, Luis
dc.contributor.authorBavestrello, Luis
dc.contributor.authorCastañeda-Méndez, Paulo F.
dc.contributor.authorVillalobos-Vindas, Juan M.
dc.contributor.authorVillegas, María Virginia
dc.contributor.orcidVillegas, María Virginia [0000-0003-1898-9067]
dc.contributor.orcidGarcia Betancur, Juan Carlos [0000-0003-3371-3384]
dc.date.accessioned2020-09-30T23:17:22Z
dc.date.available2020-09-30T23:17:22Z
dc.date.issued2020
dc.description.abstractenglishIntroduction: Carbapenemases are β-lactamases able to hydrolyze a wide range of β-lactam antibiotics, including carbapenems. Carbapenemase production in Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter spp., with and without the co-expression of other β-lactamases is a serious public health threat. Carbapenemases belong to three main classes according to the Ambler classification: class A, class B, and class D. Areas covered: Carbapenemase-bearing pathogens are endemic in Latin America. In this review, we update the status of carbapenemases in Latin America and the Caribbean. Expert opinion: Understanding the current epidemiology of carbapenemases in Latin America and the Caribbean is of critical importance to improve infection control policies limiting the dissemination of multi-drug-resistant pathogens and in implementing appropriate antimicrobial therapy.eng
dc.format.mimetypeapplication/pdf
dc.identifier.doihttps://doi.org/10.1080/14787210.2020.1813023
dc.identifier.instnameinstname:Universidad El Bosquespa
dc.identifier.issn1744-8336
dc.identifier.reponamereponame:Repositorio Institucional Universidad El Bosquespa
dc.identifier.repourlrepourl:https://repositorio.unbosque.edu.co
dc.identifier.urihttps://hdl.handle.net/20.500.12495/4222
dc.language.isoeng
dc.publisherTaylor & Francisspa
dc.publisher.journalExpert review of anti-infective therapyspa
dc.relation.ispartofseriesExpert review of anti-infective therapy, 1744-8336, 2020spa
dc.relation.urihttps://www.tandfonline.com/doi/abs/10.1080/14787210.2020.1813023?journalCode=ierz20
dc.rights.accessrightshttps://purl.org/coar/access_right/c_abf2
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess
dc.rights.accessrightsAcceso abierto
dc.rights.creativecommons2020-09-11
dc.rights.localAcceso abiertospa
dc.subject.keywordsAcinetobacter baumanniispa
dc.subject.keywordsCarbapenem resistancespa
dc.subject.keywordsCarbapenem-resistant Enterobacterales (CRE)spa
dc.subject.keywordsCarbapenemasesspa
dc.subject.keywordsCarbapenemsspa
dc.subject.keywordsKlebsiella pneumoniaespa
dc.subject.keywordsPseudomonas aeruginosaspa
dc.titleUpdate on the epidemiology of carbapenemases in Latin America and the Caribbeanspa
dc.title.translatedUpdate on the epidemiology of carbapenemases in Latin America and the Caribbeanspa
dc.type.coarhttps://purl.org/coar/resource_type/c_6501
dc.type.driverinfo:eu-repo/semantics/article
dc.type.hasversioninfo:eu-repo/semantics/publishedVersion
dc.type.localArtículo de revista

Archivos

Bloque de licencias
Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
license.txt
Tamaño:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descripción:
Descargar

Colecciones

Artículos